Surviving Males With PORCN Variants: Expanding the Clinical, Molecular, and Mechanistic Spectrum.

Clin GenetAug 10, 2026 (epub)
Case ReportMedical Genetics

Lucía Miranda-Alcaraz, Simone Carbonera, Mónica Mora-Gómez et al.

✦ AI-curated · Sources linked

Case in brief

Three male patients with pathogenic variants in the PORCN gene were identified through exome sequencing. One patient exhibited features of focal dermal hypoplasia (FDH) due to a mosaic de novo variant, while two siblings presented with a PONGOS phenotype linked to an inherited non-mosaic variant from their unaffected carrier mother. These cases demonstrate that males can survive with both types of PORCN variants.

Diagnostic / clinical pearl

Clinicians should recognize that male patients with PORCN variants can present with varying phenotypes, including milder forms, and that survival is possible with both mosaic and non-mosaic variants.

Why it matters

This case underscores the importance of understanding the clinical variability associated with PORCN variants, which has significant implications for genetic counseling and management in families with carrier mothers.

Source

Published in Clin Genet. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.